Shimizu Yuko
Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Brain Nerve. 2010 Sep;62(9):933-43.
Neuromyelitis optica (NMO) is a severe inflammatory, demyelinating disease, and its clinical characteristics include recurrent optic neuritis and longitudinally extensive transverse myelitis. The NMO-immunoglobulin (Ig) G auto-antibody (Ab), which binds to the aquaporin-4 (AQP4) water channel protein, is a marker for NMO. These clinical and immunological features have been used to distinguish NMO from multiple sclerosis (MS). In 1999, Wingerchuk et al. broadened the clinical criteria for diagnosing NMO to include "negative brain magnetic resonance imaging (MRI) at onset." However, after NMO-IgG/AQP4-Ab became a supportive criterion for diagnosing NMO, patients with NMO were frequently found to have symptomatic or asymptomatic brain lesions. In 2006, Pittock et al. reported that asymptomatic brain lesions were common in NMO, and that NMO brain lesions characteristically occurred in the hypothalamus and periventricular areas, which correspond to brain regions with high levels of AQP4 expression. Furthermore, Nakashima et al. detected abnormalities on brain MRI in 71% of NMO-IgG-positive Japanese patients. Patients with NMO have unique brain lesions that are clearly different from the lesions of patients with MS. In patients with NMO, involvement of the dorsal portion of the medulla oblongata causes intractable hiccups and nausea. Some studies described a hypothalamic lesion, and hypothalamic dysfunction could cause symptomatic hypersomnia, narcolepsy, and endocrinopathies. In some patients with NMO and NMO spectrum disorder who experience blood pressure fluctuations, vasogenic edema, manifesting as posterior reversible encephalopathy syndrome, may occur. In a recent report highlighting brain MRI with contrast enhancement, the most prominent feature that appeared to be a specific finding in NMO was "cloud-like enhancement" with multiple patchy enhancing lesions with a blurred margin. Another report showed that acute, large, edematous callosal lesions with heterogeneous intensity ("marbled pattern") occasionally occur in NMO. This review presents the characteristic clinical features of NMO according to the brain MRI findings and the features that can be used to distinguish NMO from MS.
视神经脊髓炎(NMO)是一种严重的炎症性脱髓鞘疾病,其临床特征包括复发性视神经炎和纵向广泛横贯性脊髓炎。与水通道蛋白4(AQP4)水通道蛋白结合的NMO免疫球蛋白(Ig)G自身抗体(Ab)是NMO的标志物。这些临床和免疫学特征已被用于区分NMO与多发性硬化症(MS)。1999年,Wingerchuk等人扩大了NMO的诊断临床标准,将“发病时脑磁共振成像(MRI)阴性”纳入其中。然而,在NMO-IgG/AQP4-Ab成为NMO诊断的支持标准后,经常发现NMO患者有有症状或无症状的脑病变。2006年,Pittock等人报告称,无症状脑病变在NMO中很常见,且NMO脑病变特征性地发生在下丘脑和脑室周围区域,这些区域对应于AQP4表达水平较高的脑区。此外,Nakashima等人在71%的NMO-IgG阳性日本患者中检测到脑MRI异常。NMO患者有独特的脑病变,与MS患者的病变明显不同。在NMO患者中,延髓背侧受累会导致顽固性呃逆和恶心。一些研究描述了下丘脑病变,下丘脑功能障碍可导致症状性嗜睡、发作性睡病和内分泌病。在一些经历血压波动的NMO和NMO谱系障碍患者中,可能会发生表现为后部可逆性脑病综合征的血管源性水肿。在最近一篇强调对比增强脑MRI的报告中,似乎是NMO特异性表现的最突出特征是“云状强化”,伴有多个边界模糊的斑片状强化病变。另一篇报告显示,NMO偶尔会出现急性、大的、水肿性胼胝体病变,强度不均匀(“大理石样图案”)。本综述根据脑MRI结果介绍了NMO的特征性临床特征以及可用于区分NMO与MS的特征。